Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer
1994

Photodynamic Therapy for Skin Cancer

Sample size: 36 publication Evidence: moderate

Author Information

Author(s): F. Cairnduff, M.R. Stringer, E.J. Hudson, D.V. Ash, S.B. Brown

Primary Institution: Cookridge Hospital, University of Leeds

Hypothesis

Can superficial photodynamic therapy using topical 5-aminolaevulinic acid effectively treat superficial primary and secondary skin cancers?

Conclusion

The study found that superficial photodynamic therapy with ALA cream resulted in a high complete response rate for Bowen's disease but less effective results for basal cell carcinomas and poor responses for metastatic lesions.

Supporting Evidence

  • Complete response rate of 89% for Bowen's disease at 18 months follow-up.
  • 50% complete response rate for basal cell carcinomas at 17 months follow-up.
  • Metastatic lesions showed poor response to treatment.

Takeaway

Doctors used a special cream and light to treat skin cancer, and it worked really well for some types but not for others.

Methodology

The study involved applying 20% ALA cream to skin lesions, followed by light treatment with a specific wavelength, and assessing the response over time.

Limitations

The study had a small sample size and less effective results for basal cell carcinomas and metastatic lesions.

Participant Demographics

Patients included those with Bowen's disease, basal cell carcinomas, and metastatic skin cancers, with a median follow-up of 18 months.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication